Literature DB >> 2959252

Atrial and ventricular myosins from human hearts. I. Isoenzyme distribution during development and in the adult.

U Hoffmann1, E Siegert.   

Abstract

Two distinct types of native isomyosins, referred to as human fetal HF and human ventricular myosin HV-3, have been identified in the human fetal heart during two different periods of gestation and in the neonatal state, whose relative parts change with development. In the adult ventricle, only HV-3 was found. Two myosin isoforms designated as HA-3 and HA-1 occur in the atrial myocardium of the normal human heart, which are electrophoretically distinct from the fetal isoenzymes. In fetal tissue, the myosin light chain complement is composed of atrial and ventricular light chains. In support of recent results, we also found identical spots from the atrial ALC-1 and the fetal light chain FLC, suggesting a homology between them. Apart from the light chains typical for this tissue, the atrial myocardium also contains ventricular light chains. Therefore we hypothesize that atrial myosin consists of two atrial isoenzymes and presumably of a ventricular type, too. Differences between atrial and ventricular myosin from human hearts were demonstrated by measuring the temperature dependence of the Ca2+-ATPase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2959252     DOI: 10.1007/bf01907022

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  29 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Purification of cardiac myosin. Application to hypertrophied myocardium.

Authors:  K T Shiverick; L L Thomas; N R Alpert
Journal:  Biochim Biophys Acta       Date:  1975-05-30

3.  Enzymatic comparisons between light chain isozymes of human cardiac myosin subfragment-1.

Authors:  L S Tobacman; R S Adelstein
Journal:  J Biol Chem       Date:  1984-09-25       Impact factor: 5.157

4.  Myosin changes in hypertrophied human atrial and ventricular myocardium. A correlated immunofluorescence and quantitative immunochemical study on serial cryosections.

Authors:  S Schiaffino; L Gorza; L Saggin; C Valfré; S Sartore
Journal:  Eur Heart J       Date:  1984-12       Impact factor: 29.983

5.  Electrophoretic analyses of atrial and ventricular cardiac myosins from foetal and adult rabbits.

Authors:  T Srihari; C R Tuchschmid; H O Hirzel; M C Schaub
Journal:  Comp Biochem Physiol B       Date:  1982

6.  Transitions in human atrial and ventricular myosin light-chain isoenzymes in response to cardiac-pressure-overload-induced hypertrophy.

Authors:  P Cummins
Journal:  Biochem J       Date:  1982-07-01       Impact factor: 3.857

7.  Structural and enzymatic comparison of human cardiac muscle myosins isolated from infants, adults, and patients with hypertrophic cardiomyopathy.

Authors:  J J Schier; R S Adelstein
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

8.  Regulation of myosin isoenzyme composition in fetal and neonatal rat ventricle by endogenous thyroid hormones.

Authors:  R A Chizzonite; R Zak
Journal:  J Biol Chem       Date:  1984-10-25       Impact factor: 5.157

9.  Myosin subunit composition in human developing muscle.

Authors:  D Biral; E Damiani; A Margreth; E Scarpini
Journal:  Biochem J       Date:  1984-12-15       Impact factor: 3.857

10.  Myosin types and fiber types in cardiac muscle. I. Ventricular myocardium.

Authors:  S Sartore; L Gorza; S Pierobon Bormioli; L Dalla Libera; S Schiaffino
Journal:  J Cell Biol       Date:  1981-01       Impact factor: 10.539

View more
  2 in total

1.  Atrial and ventricular myosins from human hearts. II. Isoenzyme distribution after myocardial infarction.

Authors:  U Hoffmann; C Axmann; N Palm
Journal:  Basic Res Cardiol       Date:  1987 Jul-Aug       Impact factor: 17.165

2.  Differences between atrial and ventricular protein profiling in children with congenital heart disease.

Authors:  V Pelouch; M Milerová; B Ostádal; B Hucín; M Samánek
Journal:  Mol Cell Biochem       Date:  1995 Jun 7-21       Impact factor: 3.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.